Cancer care is complex.
Cancer is a complex disease of the genome, which makes decisions about cancer care difficult–for providers and patients alike. Despite advances in genomics, many patients never get the biomarker testing they need to be matched with life-saving targeted therapies.1
Genomic testing shouldn’t be.
Biofidelity’s unique technologies make it easier to get precision-driven genomic insights at every stage of the patient journey. With our products, genomic biomarker detection is simple, fast and reliable, enabling more patients to get the right treatment at the right time.
A solution for every stage of the patient journey.
Our two innovative technologies, Aspyre® and Enspyre®, comprise an end-to-end solution for every stage of the cancer patient journey—from early detection to treatment selection to minimal residual disease detection and monitoring.
